Cargando…

Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma

Detalles Bibliográficos
Autores principales: Sarnaik, Amod, Hall, MacLean, Mullinax, John, Royster, Erica, Richards, Allison, Crago, Georgina, Zager, Jonathan, Vernon, Sondak, Weber, Jeffrey, Pilon-Thomas, Shari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645282/
http://dx.doi.org/10.1186/2051-1426-3-S2-P49
_version_ 1782400798661017600
author Sarnaik, Amod
Hall, MacLean
Mullinax, John
Royster, Erica
Richards, Allison
Crago, Georgina
Zager, Jonathan
Vernon, Sondak
Weber, Jeffrey
Pilon-Thomas, Shari
author_facet Sarnaik, Amod
Hall, MacLean
Mullinax, John
Royster, Erica
Richards, Allison
Crago, Georgina
Zager, Jonathan
Vernon, Sondak
Weber, Jeffrey
Pilon-Thomas, Shari
author_sort Sarnaik, Amod
collection PubMed
description
format Online
Article
Text
id pubmed-4645282
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46452822015-11-20 Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma Sarnaik, Amod Hall, MacLean Mullinax, John Royster, Erica Richards, Allison Crago, Georgina Zager, Jonathan Vernon, Sondak Weber, Jeffrey Pilon-Thomas, Shari J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645282/ http://dx.doi.org/10.1186/2051-1426-3-S2-P49 Text en Copyright © 2015 Sarnaik et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Sarnaik, Amod
Hall, MacLean
Mullinax, John
Royster, Erica
Richards, Allison
Crago, Georgina
Zager, Jonathan
Vernon, Sondak
Weber, Jeffrey
Pilon-Thomas, Shari
Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
title Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
title_full Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
title_fullStr Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
title_full_unstemmed Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
title_short Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
title_sort clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645282/
http://dx.doi.org/10.1186/2051-1426-3-S2-P49
work_keys_str_mv AT sarnaikamod clinicalresultsofcombinedvemurafenibandtumorinfiltratinglymphocytetherapyformetastaticmelanoma
AT hallmaclean clinicalresultsofcombinedvemurafenibandtumorinfiltratinglymphocytetherapyformetastaticmelanoma
AT mullinaxjohn clinicalresultsofcombinedvemurafenibandtumorinfiltratinglymphocytetherapyformetastaticmelanoma
AT roystererica clinicalresultsofcombinedvemurafenibandtumorinfiltratinglymphocytetherapyformetastaticmelanoma
AT richardsallison clinicalresultsofcombinedvemurafenibandtumorinfiltratinglymphocytetherapyformetastaticmelanoma
AT cragogeorgina clinicalresultsofcombinedvemurafenibandtumorinfiltratinglymphocytetherapyformetastaticmelanoma
AT zagerjonathan clinicalresultsofcombinedvemurafenibandtumorinfiltratinglymphocytetherapyformetastaticmelanoma
AT vernonsondak clinicalresultsofcombinedvemurafenibandtumorinfiltratinglymphocytetherapyformetastaticmelanoma
AT weberjeffrey clinicalresultsofcombinedvemurafenibandtumorinfiltratinglymphocytetherapyformetastaticmelanoma
AT pilonthomasshari clinicalresultsofcombinedvemurafenibandtumorinfiltratinglymphocytetherapyformetastaticmelanoma